Sex Selection of Human Spermatozoa
Part of paid clinical trials in New York, New York.
- Sponsor
- Weill Medical College of Cornell University
- Study ID
- NCT05500573
- Status
- Recruiting
Conditions
- IVF
- Infertility
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 89 Years
- Healthy Volunteers
- Accepted
Interventions
- Sperm Sorting — PROCEDURESelection of gender specific spermatozoa using a multilayer density gradient solution
Study Details
This study aims to demonstrate a reliable method of selecting gender specific sperm. X-bearing spermatozoa and Y-bearing spermatozoa will be identified from the density gradient layers. The selected gender specimen will then be utilized for assisted reproductive fertilization- in vitro fertilization or intrauterine insemination which are routine standard of care procedures.
Key Dates
- Start date
- Nov 6, 2013
- Status verified
- May 2026
- Primary completion
- Dec 31, 2028
- Completion
- Dec 31, 2029
Study Design
- Enrollment
- 2,000 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Sperm sortingSelection of gender specific spermatozoa using a multilayer density gradient
Primary Outcome Measure
Rate of gender bearing spermatozoa after 4-layer density gradient [ Time Frame: 8 years ]
Central Contacts
- Rodriq Stubbs, MS, NP646-962-3276
- Stephanie Cheung646-962-8448
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Center for Reproductive Medicine- Weill Cornell Medicine | New York | New York | 10021 |
Find similar trials in New York, NY
Related Studies
- Gamete Treatment to Correct Fertilization FailureRecruiting · Weill Medical College of Cornell University · New York, New York
- Use of Artificial Intelligence for Clinical Assessment of Assisted Reproductive Techniques and IVF OutcomesRecruiting · Weill Medical College of Cornell University · New York, New York
- Ovarian PRP Injections for Improved Embryo Quality Using Embryo Quality ScoreRecruiting · Generation Next Fertility · New York, New York
- Study to Create Potential Cell-Based Therapies to Treat Human Disease and DisabilityEnrolling By Invitation · Stanford University · Stanford, California